Literature DB >> 9657691

Phosphatidylinositol 3,4,5-trisphosphate triggers platelet aggregation by activating Ca2+ influx.

P J Lu1, A L Hsu, D S Wang, C S Chen.   

Abstract

Exogenous phosphatidylinositol 3,4,5-trisphosphate [PtdIns(3,4,5)P3] stimulates the aggregation of washed rabbit platelets in a Ca2+- and dose-dependent manner. This aggregation is reversible at low PtdIns(3,4,5)P3 levels, but becomes irreversible when the concentration exceeds a threshold of about 20 microM. Other D-3 and D-4 phosphoinositides examined, including phosphatidylinositol 3, 4-bisphosphate [PtdIns(3,4)P2], phosphatidylinositol 4, 5-bisphosphate [PtdIns(4,5)P2], and phosphatidylinositol 3-monophosphate [PtdIns(3)P], fail to exert appreciable platelet activation at comparable concentrations. In addition, PtdIns(3,4, 5)P3 can reverse the inhibitory effect of wortmannin on thrombin-induced platelet aggregation. Taken together with the observation that PtdIns(3,4,5)P3 is readily incorporated into cell membranes, these findings reaffirm the second messenger role of PtdIns(3,4,5)P3 in thrombin receptor activation. The existence of a PtdIns(3,4,5)P3-dependent Ca2+ entry system on platelet membranes is supported by the partial inhibition of thrombin-induced Ca2+ influx by wortmannin. Evidence suggests that this system differs from receptor-operated nonselective Ca2+ channels. However, the mechanism by which PtdIns(3,4,5)P3 facilitates Ca2+ entry remains unclear. Although PtdIns(3,4,5)P3 has been known to stimulate phospholipase C-gamma (PLC-gamma), internal Ca2+ mobilization does not play a significant role in the cytosolic Ca2+ increase in response to PtdIns(3,4,5)P3 stimulation. Collectively, these data provide a putative link between PtdIns(3,4,5)P3 and Ca2+ signaling, which may, in part, account for the regulatory function of PtdIns(3,4,5)P3 during platelet aggregation. Moreover, this study bears out the notion that individual PI 3-kinase lipid products play distinct roles in the regulation of cellular functions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9657691     DOI: 10.1021/bi980163o

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

Review 1.  The diacylgylcerol-sensitive TRPC3/6/7 subfamily of cation channels: functional characterization and physiological relevance.

Authors:  Alexander Dietrich; Hermann Kalwa; Benjamin R Rost; Thomas Gudermann
Journal:  Pflugers Arch       Date:  2005-06-22       Impact factor: 3.657

Review 2.  Functional characterization and physiological relevance of the TRPC3/6/7 subfamily of cation channels.

Authors:  Alexander Dietrich; Michael Mederos y Schnitzler; Hermann Kalwa; Ursula Storch; Thomas Gudermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04       Impact factor: 3.000

3.  Phosphatidylinositol 3,4,5-trisphosphate regulates Ca(2+) entry via btk in platelets and megakaryocytes without increasing phospholipase C activity.

Authors:  J M Pasquet; L Quek; C Stevens; R Bobe; M Huber; V Duronio; G Krystal; S P Watson
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

4.  Protease activated receptors in cardiovascular function and disease.

Authors:  Junor A Barnes; Shamjeet Singh; Aldrin V Gomes
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

5.  Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice.

Authors:  Juhua Chen; Sarmishtha De; Derek S Damron; William S Chen; Nissim Hay; Tatiana V Byzova
Journal:  Blood       Date:  2004-04-22       Impact factor: 22.113

6.  Non-redundant roles of phosphoinositide 3-kinase isoforms alpha and beta in glycoprotein VI-induced platelet signaling and thrombus formation.

Authors:  Karen Gilio; Imke C A Munnix; Pierre Mangin; Judith M E M Cosemans; Marion A H Feijge; Paola E J van der Meijden; Servé Olieslagers; Magdalena B Chrzanowska-Wodnicka; Rivka Lillian; Simone Schoenwaelder; Shigeo Koyasu; Stewart O Sage; Shaun P Jackson; Johan W M Heemskerk
Journal:  J Biol Chem       Date:  2009-10-08       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.